Pericarditis Acute: Clinical Trials

3 trials for Pericarditis Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated, 1 unknown. 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1
Phase 31Recruiting 1
Phase 41Terminated 1

Follow Pericarditis Acute: new trials by email Literature Review of Pericarditis Acute trials Research Report on Pericarditis Acute

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
KPL-387, Placebo - Pericarditis, Pericarditis Acute
Phase 2 / Phase 3RecruitingKiniksa Pharmaceuticals International, plc3252025-07-252026-10-19
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
Stand of care ECG, Holter, MRI, ECHO, Quality of life questionnaire, Baseline Quality of Life questionnaire - Myocarditis, Myocarditis Acute
UnknownCardiology Research UBC5002023-04-232023-10-26
Dexamethasone Compared to Non-steroidal Anti-inflammatory Drugs in the Treatment of Acute Pericarditis
Dexamethasone therapy, NSAID therapy - Pericarditis Acute
Phase 4TerminatedRabin Medical Center102020-02-142023-12-19

Narrower conditions

Pericarditis (2)  ·  Myocarditis (1)  ·  Recurrence (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Cardiomyopathies (1)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Caves (1)  ·  Magnetic Resonance Imaging (1)

Sponsors

Cardiology Research UBC (1)  ·  Kiniksa Pharmaceuticals International, plc (1)  ·  Rabin Medical Center (1)

Countries

Canada (2)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Serbia (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Nathaniel Hawkins, MD (1)  ·  Nili Schamroth Pravda, MbbCH (1)

NIH funding

2025 (1)